These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 12883328

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa.
    Peter K, Graeber J, Kipriyanov S, Zewe-Welschof M, Runge MS, Kübler W, Little M, Bode C.
    Circulation; 2000 Mar 14; 101(10):1158-64. PubMed ID: 10715263
    [Abstract] [Full Text] [Related]

  • 3. Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin.
    Bode C, Hudelmayer M, Mehwald P, Bauer S, Freitag M, von Hodenberg E, Newell JB, Kübler W, Haber E, Runge MS.
    Circulation; 1994 Oct 14; 90(4):1956-63. PubMed ID: 7923685
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of hirudin fusion proteins in mammalian cells: a strategy for prevention of intravascular thrombosis.
    Riesbeck K, Chen D, Kemball-Cook G, McVey JH, George AJ, Tuddenham EG, Dorling A, Lechler RI.
    Circulation; 1998 Dec 15; 98(24):2744-52. PubMed ID: 9851962
    [Abstract] [Full Text] [Related]

  • 6. Is the inhibition of both clot-associated thrombin and factor Xa more clinically relevant than either one alone?
    Meddahi S, Samama MM.
    Blood Coagul Fibrinolysis; 2009 Apr 15; 20(3):207-14. PubMed ID: 19657318
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vasoflux, a new anticoagulant with a novel mechanism of action.
    Weitz JI, Young E, Johnston M, Stafford AR, Fredenburgh JC, Hirsh J.
    Circulation; 1999 Feb 09; 99(5):682-9. PubMed ID: 9950667
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
    Rubens FD, Weitz JI, Brash JL, Kinlough-Rathbone RL.
    Thromb Haemost; 1993 Feb 01; 69(2):130-4. PubMed ID: 8456425
    [Abstract] [Full Text] [Related]

  • 14. A screening procedure to evaluate the anticoagulant activity and the kinetic behaviour of direct thrombin inhibitors.
    Rupin A, Mennecier P, de Nanteuil G, Laubie M, Verbeuren TJ.
    Thromb Res; 1995 May 01; 78(3):217-25. PubMed ID: 7631302
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of thrombin by hirudin genetically fused to wild-type or mutant antithrombin.
    Syed S, Kelly KE, Sheffield WP.
    Thromb Res; 1996 Dec 15; 84(6):419-29. PubMed ID: 8987163
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structure-activity relationships of recombinant hirudins.
    Stürzebecher J, Walsmann P.
    Semin Thromb Hemost; 1991 Apr 15; 17(2):94-8. PubMed ID: 1771418
    [Abstract] [Full Text] [Related]

  • 18. New anticoagulant protein from medicinal leech.
    Manuvera VA, Kharlampieva DD, Bobrovsky PA, Grafskaia EN, Brovina KA, Lazarev VN.
    Biochem Biophys Res Commun; 2024 Feb 12; 696():149473. PubMed ID: 38241814
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH, Sze P, Winant RC, Hudson D, Underhill P, Lazar JB, Olsen C, Almquist R.
    Haemostasis; 1991 Feb 12; 21 Suppl 1():41-8. PubMed ID: 1894196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.